chr16-89791538-T-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000135.4(FANCA):c.1226-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000341 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000135.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000135.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | NM_000135.4 | MANE Select | c.1226-2A>G | splice_acceptor intron | N/A | NP_000126.2 | |||
| FANCA | NM_001286167.3 | c.1226-2A>G | splice_acceptor intron | N/A | NP_001273096.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | TSL:1 MANE Select | c.1226-2A>G | splice_acceptor intron | N/A | ENSP00000373952.3 | |||
| FANCA | ENST00000567205.2 | TSL:1 | n.1226-2A>G | splice_acceptor intron | N/A | ENSP00000457027.2 | |||
| FANCA | ENST00000564475.6 | TSL:2 | c.1226-2A>G | splice_acceptor intron | N/A | ENSP00000454977.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 250800 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461726Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727152 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74348 show subpopulations
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Pathogenic:6
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.
This is a single nucleotide variant located two bases upstream of exon 13 of the FANCA gene. This alteration is predicted to cause aberrant mRNA splicing, resulting in a non-functional protein (PMID:16199547). Loss-of-function variants in the FANCA gene are classified as pathogenic (PMID:19367192). This specific variant is listed in population databases (rs773906241, gnomAD frequency:0.01%) and is also recorded in the ClinVar database (VCV000439688.30). In conclusion, based on the above evidence, this variant is classified as pathogenic.
Fanconi anemia Pathogenic:2
This sequence change affects an acceptor splice site in intron 13 of the FANCA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is present in population databases (rs773906241, gnomAD 0.01%). Disruption of this splice site has been observed in individuals with Fanconi anemia (PMID: 29098742; internal data). ClinVar contains an entry for this variant (Variation ID: 439688). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
not specified Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at